Chronic obstructive pulmonary disease therapy.docVIP

 PAGE \* MERGEFORMAT 13 Chronic obstructive pulmonary disease therapy Abstract: Chronic obstructive pulmonary disease (COPD) is a kind of disease characterized by airflow limitation, is not fully reversible airflow limitation, showed a progressive development, and the lungs of harmful gases or harmful particles in the abnormal inflammatory response. Cough , sputum, shortness of breath, wheezing and chest tightness as the main clinical symptoms. more than the number of patients because of its high mortality, socio-economic burden, has become an important public health issue. quitting smoking is considered to be the only slow the progress of COPD effective measures. drug treatment for the prevention and control symptoms, reduce the frequency and severity of acute exacerbations, increase exercise tolerance and quality of life. now in stable COPD medications reviewed in this paper. Keywords:: chronic obstructive pulmonary disease Chronic bronchitis (chronic bronchitis, referred to as chronic bronchitis) is the trachea, bronchial mucosa and surrounding tissue of chronic non-specific inflammation. Clinically by cough, expectoration, or accompanied by wheezing and a chronic recurrent course characterized. Lung species (pulmonary emphysema) is a remote terminal bronchioles (respiratory bronchioles, alveolar ducts, alveolar sacs and alveolar) decreased elasticity of the airway, excessive swelling, accompanied by hyperinflation or airway wall damage pathological conditions. Chronic obstructive pulmonary disease (chronic obstructive pulmonary disease, COPD) is defined as: with airflow obstruction (airflow obstruction) the characteristics of chronic bronchitis and emphysema. Showed progressive development of airflow obstruction, but some are reversible. A known cause or with a specific pathology and have airflow obstruction in diseases such as cystic fibrosis, obliterative bronchiolitis and asthma is not a COPD. 1. Bronchodilator bronchodilat